WAINUA

Generic Name/API: eplontersen

Manufacturer: AstraZeneca Pharmaceuticals LP

Dosage Forms & Strength & Pack Size:
Injection: 45 mg/0.8 mL in a single-dose autoinjector.

Storage:
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton protected from light.
If needed, WAINUA can be kept at room temperature (up to 30°C [86°F]) in the original
carton for up to 6 weeks. If not used within the 6 weeks stored at room temperature,
discard WAINUA.
Do not freeze. Do not expose to heat.

  • INDICATION
  • IMPORTANT SAFETY INFORMATION

INDICATION
WAINUA injection, for subcutaneous use, 45 mg is a prescription medicine used to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.

IMPORTANT RISK INFORMATION
WAINUA may cause side effects, including:
Low vitamin A level, which is a serious, but common side effect of treatment with WAINUA. Your doctor should tell you to take vitamin A supplements. Do not take more than the amount of vitamin A your doctor has recommended. Call your doctor if you develop eye problems such as difficulty seeing at night or in low-lit areas (night blindness), or dry eyes. If you develop eye problems, your doctor should refer you to an eye doctor
The most common side effects include decreased vitamin A and vomiting.

Before you take WAINUA, tell your healthcare provider:

if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if WAINUA can harm your baby. Changes in vitamin A levels and vitamin A supplementation related to use of WAINUA may harm your unborn baby. It is not known if WAINUA passes into breast milk
about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take vitamin A or beta-carotene supplements

Scroll to Top